BioCryst Reports Second Quarter 2026 Financial Results

Go back to BioCryst Reports Second Quarter 2026 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.44 -0.13 (1.52%)
Previous Close $8.57    52 Week High $10.98 
Open $8.54    52 Week Low $1.63 
Day High $8.65    P/E N/A 
Day Low $8.40    EPS $-0.68 
Volume 2,828,885